BIOC

Stats

Summary

biocept is a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor associated dna , both in circulating tumor cells (ctcs) and in plasma (cell free circulating tumor dna). our mission is to improve outcomes for cancer patients by advancing oncology diagnostics. we utilize patented and innovative technologies to deliver clinically relevant oncology diagnostics to physicians by providing advanced prognostic and predictive assessments for guiding the course of treating patients. additionally, we offer services to other laboratory testing providers, academic institutions, research organizations, biopharmaceutical companies, and clinical trial support. our strategic focus is to promote our unique targeted selector™ technology to the oncology community. our target selector technology has demonstrated that it can consistently capture extremely rare cells which may be present in only 1 of every 50-100 billion blood cells. examples of these rare cells ar

Market Cap: 1.31 Million

Primary Exchange: NASDAQ

Website: https://biocept.com/

Shares Outstanding: 2.63 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 12.865859717250512

Sector: Health Care and Social Assistance

Industry: Medical Laboratories

Ethical Flags

Longest drawdown: 2829 trading days

From: 2014-02-18 To: 2023-10-24

Lowest Point:

Ex-Date	Payment Date	Record Date	Declared Date	Amount	Flag	Dividend Type	Qualified	Indicated

Ex-Date	Declared Date	Record Date	Payment Date	Ratio	To Factor	For Factor
2016-09-29				3.0	1.0	3.0